Survival rate (95% confidence interval)

1 year

3 years

5 years

p-value

Overall survival^a

95.2 (82.2 - 98.8)

56.3 (36.0 - 72.4)

42.6 (23.2 - 60.8)

Age (years)

<60

75.0 (12.8 - 96.1)

75.0 (12.8 - 96.1)

0.475

60 - 70

82.2 (45.5 - 95.2)

41.1 (10.0 - 70.9)

70 - 80

94.1 (65.0 - 99.2)

51.3 (20.3 - 75.7)

>80

80.0 (20.4 - 96.9)

ISUP grade group^b

1

50.0 (0.6 - 91.0)

0.061

2

66.7 (5.4 - 9.5)

3

85.7 (33.4 - 97.9)

64.3 (15.2 - 90.2)

4

76.2 (33.2 - 93.5)

19.1 (0.9 - 55.9)

5

90.9 (50.8 - 98.7)

35.5 (8.6 - 64.5)

11.8 (1.0 - 40.4)

PSA (initial, ng/mL)

≤100^c

80.8 (42.4 - 94.9)

0.461

>100^d

88.9 (69.4 - 96.3)

PSA (nadir, ng/mL)

<4

100

83.1 (47.2 - 95.5)

83.1 (47.2 - 95.5)

0.005

≥4

91.6 (70.2 - 97.8)

29.2 (7.6 - 55.6)

9.7 (0.6 - 34.8)

<4 in ≤12 mo

100

83.1 (47.2 - 95.5)

83.1 (47.2 - 95.5)

0.002

<4 in >12 mo

100

66.7 (5.4 - 94.5)

0

≥4 in >12 mo

91.6 (70.2 - 97.8)

29.2 (7.6 - 55.6)

9.7 (0.6 - 34.8)

Time to PSA nadir

≤6 months

100

43.7 (17.0 - 67.9)

34.9 (11.3 - 60.2)

0.263

7 - 12 months

100

62.5 (14.2 - 89.3)

62.5 (14.2 - 89.3)

>12 months

100

83.3 (27.3 - 97.5)

62.5 (14.2 - 89.3)

HN or paralysis

Present

86.5 (55.8 - 96.5)

16.5 (1.1 - 48.7)

0.090

Absent

96.2 (75.7 - 99.5)

47.5 (21.3 - 69.9)

HT or diabetes

Present

90.9 (50.8 - 98.7)

35.4 (6.1 - 68.0)

0.757

Absent

93.3 (75.7 - 98.3)

38.0 (16.2 - 59.9)